CARLSBAD, CA — January 8, 2026 — Leads & Copy — Aurora Spine Corporation announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The patents strengthen the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.
The first patent, No. 12,478,411 B2, is titled Spinal Implant for Motion Preservation or Fusion. It represents the tenth issued U.S. patent supporting the ZIP™ implant family and expands the protected design space around Aurora Spine’s platform.
The patented technology covers a spinal implant architecture designed to support either motion preservation or fusion, depending on clinical application. The design incorporates interacting structural components that distribute load and engage progressively under physiological forces. This addresses limitations of traditional rigid implants while maintaining stability and durability.
Trent J. Northcutt, President and Chief Executive Officer of Aurora Spine, said the issuance of the tenth patent for the ZIP implant family highlights the platform’s strength, longevity, and originality. He added that ZIP has been a foundational technology for the company and this milestone reinforces their ability to protect and evolve solutions that address real biomechanical and clinical challenges in spine surgery.
The second patent, U.S. Patent No. 12,478,481 B2, is titled Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use. It protects technology focused on selecting orthopedic implants based on a patient’s bone density scan results, such as DEXA measurements.
The patented method establishes a structured, data-driven framework that enables surgeons to:
- Utilize objective bone density data to guide implant selection
- Match implant characteristics to patient bone quality
- Apply a standardized approach across varying bone density profiles
This technology forms the basis of Aurora Spine’s DEXA Technology™ platform, which represents the company’s third bone-density-matched implant system patent.
Laszlo Garamszegi, Chief Technology Officer and Co-Founder of Aurora Spine, said bone quality is one of the most important variables in spine surgery, yet it has historically been underutilized in implant selection. He added that this patent establishes a formal, repeatable method for aligning implant selection with patient bone characteristics using objective data.
The same-day issuance of these two patents underscores Aurora Spine’s continued investment in diverse, non-overlapping innovation pathways. Each patent independently supports future product development, clinical differentiation, and long-term shareholder value while reinforcing the company’s reputation for meaningful, surgeon-driven innovation.
Both patents are now issued and enforceable in the United States.
Aurora Spine Corporation is an innovative designer and manufacturer of minimally invasive spinal implants and interventional pain management technologies. Headquartered in Carlsbad, California, the company’s mission is to improve spinal surgery outcomes through simplified, integrated, and cost-effective solutions that advance patient care worldwide.
Company and Investor Contacts:
Aurora Spine Corporation
Trent J. Northcutt
President and Chief Executive Officer
Phone: (760) 424-2004
Chad Clouse
Chief Financial Officer
Phone: (760) 424-2004
Investor Relations
Adam Lowensteiner
Lytham Partners
Phone: (646) 829-9702
Email: asapf@lythampartners.com
Source: Aurora Spine Corporation
